Security
Intelligent Bio Solutions Inc. Common Stock · INBS
INBSNASDAQCommon stockCurrentCIK 1725430Updated Oct 26, 2026
Name history
GBS Inc. · through Oct 18, 2022Glucose Biosensor Systems (Greater China) Holdings, Inc. · through Sep 19, 2019
INBS price & chart
Loading TradingView…
NASDAQ:INBS on TradingView ↗About the company
Bio Solutions Inc. Intelligent Bio Solutions Inc. (Nasdaq: INBS) is a medical technology company delivering intelligent, rapid, non-invasive testing solutions. The Company believes that its Intelligent Fingerprinting Drug Screening System will revolutionize portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields. Designed as a hygienic and cost-effective system, the test screens for the recent use of drugs commonly found in the workplace, including opiates, cocaine, methamphetamine, and cannabis. With sample collection in seconds and results in under ten minutes, this technology would be a valuable tool for employers in safety-critical industries. The Company’s current customer segments outside the U.S. include construction, manufacturing and engineering, transport and logistics firms, mining, drug treatment organizations, and coroners.
In the news
Recent filings
PRE 14A filing
10-K/A filing
Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year · Regulation FD Disclosure
Items 5.03, 7.01, 9.01
EFFECT filing
424B3 filing
Show 5 more recent filings
S-3 filing
D filing
Items 06b
Other Events
Items 8.01
Regulation FD Disclosure · Other Events
Items 7.01, 8.01, 9.01
Entry into a Material Definitive Agreement · Unregistered Sales of Equity Securities · Regulation FD Disclosure
Items 1.01, 3.02, 7.01, 9.01
Financials
FY 2026 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | Q3 2026 | Q3 2025 | Q3 2024 | Q2 2026 | Q2 2025 | Q2 2024 | Q1 2026 | Q1 2025 | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| AssetsUSD | 14,862,792Source | 9,584,527Source | 17,038,953Source | 17,653,042Source | 8,683,975Source | 8,826,992Source | 10,038,309Source | 11,725,883Source | 11,941,836Source | 8,249,786Source | 13,778,863Source | 10,354,612Source |
| Property, Plant and Equipment, NetUSD | 312,276Source | 546,458Source | 559,520Source | 321,741Source | 537,225Source | 591,307Source | 271,745Source | 586,120Source | 294,399Source | 251,325Source | 565,850Source | 690,175Source |
| Intangible Assets, Net (Excluding Goodwill)USD | 2,999,174Source | 3,803,940Source | 4,593,330Source | 3,269,439Source | 3,902,587Source | 4,858,301Source | 3,473,303Source | 4,400,092Source | 2,799,161Source | 3,790,319Source | 4,372,026Source | 5,255,401Source |
| Current assets: | ||||||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 6,862,204Source | 2,807,112Source | 9,397,523Source | 740,371Source | 2,242,209Source | 1,119,004Source | 1,660,105Source | 3,989,431Source | 3,992,312Source | 1,019,909Source | 6,304,098Source | 1,537,244Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 878,357Source | 510,963Source | 431,646Source | 456,657Source | 266,080Source | 262,834Source | 717,823Source | 578,578Source | 848,464Source | 594,614Source | 429,704Source | 293,861Source |
| Inventory, NetUSD | 597,469Source | 683,488Source | 877,905Source | 590,246Source | 701,280Source | 942,050Source | 628,177Source | 738,789Source | 418,577Source | 635,215Source | 777,537Source | 979,907Source |
| Assets, CurrentUSD | 9,749,720Source | 5,107,331Source | 11,520,591Source | 12,174,684Source | 4,061,526Source | 2,944,656Source | 4,484,369Source | 6,478,911Source | 7,097,236Source | 4,138,622Source | 8,534,243Source | 3,862,561Source |
| Prepaid Expense and Other Assets, CurrentUSD | 843,090Source | — | — | — | — | — | — | — | 1,030,932Source | — | — | — |
| Operating Lease, Right-of-Use AssetUSD | 1,801,622Source | 126,798Source | 365,512Source | 1,887,178Source | 182,637Source | 432,728Source | 1,808,892Source | 260,760Source | 1,751,040Source | 69,520Source | 306,744Source | 546,475Source |
| LIABILITIES AND EQUITY | ||||||||||||
| LiabilitiesUSD | 6,111,476Source | 4,640,761Source | 6,041,181Source | 6,763,231Source | 4,480,587Source | 5,672,758Source | 6,611,380Source | 5,776,641Source | 6,651,010Source | 5,435,962Source | 5,595,672Source | 6,667,614Source |
| Stockholders’ equity: | ||||||||||||
| Common Stock, Value, IssuedUSD | 20,012Source | 67,941Source | 29,135Source | 12,384Source | 48,068Source | 14,760Source | 90,985Source | 43,775Source | 29,056Source | 73,230Source | 34,557Source | 23,304Source |
| Additional Paid in CapitalUSD | 80,497,637Source | 65,012,004Source | 60,946,174Source | 79,540,489Source | 61,856,832Source | 49,986,220Source | 69,325,542Source | 61,207,017Source | 80,992,006Source | 65,783,916Source | 60,971,740Source | 46,158,763Source |
| Retained Earnings (Accumulated Deficit)USD | -71,056,373Source | -59,442,961Source | -49,180,085Source | -68,193,661Source | -56,899,435Source | -46,202,418Source | -65,516,071Source | -54,649,965Source | -74,964,040Source | -62,533,065Source | -51,964,332Source | -41,807,573Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | -499,710Source | -523,417Source | -662,405Source | -266,079Source | -639,424Source | -518,379Source | -279,228Source | -496,259Source | -546,186Source | -327,944Source | -712,614Source | -575,496Source |
| Stockholders' Equity Attributable to ParentUSD | 8,961,565Source | 5,113,566Source | 11,132,818Source | 11,093,132Source | 4,366,040Source | 3,280,182Source | 3,621,227Source | 6,104,567Source | 5,510,835Source | 2,996,136Source | 8,329,350Source | 3,798,984Source |
| Liabilities and EquityUSD | 14,862,792Source | 9,584,527Source | 17,038,953Source | 17,653,042Source | 8,683,975Source | 8,826,992Source | 10,038,309Source | 11,725,883Source | 11,941,836Source | 8,249,786Source | 13,778,863Source | 10,354,612Source |
| Current liabilities: | ||||||||||||
| Liabilities, CurrentUSD | 4,611,102Source | 4,564,385Source | 5,706,307Source | 5,127,241Source | 4,402,769Source | 5,183,086Source | 5,062,074Source | 5,678,799Source | 4,928,924Source | 5,351,041Source | 5,450,733Source | 5,883,685Source |
| Operating Lease, Liability, CurrentUSD | 388,746Source | 151,322Source | 260,377Source | 382,518Source | 205,945Source | 250,751Source | 362,801Source | 281,565Source | 147,005Source | 84,659Source | 274,834Source | 223,447Source |
| Accounts Payable, CurrentUSD | — | — | — | — | — | — | — | — | 712,449Source | — | — | — |
| Operating Lease, Liability, NoncurrentUSD | 1,459,678Source | 3,704Source | 154,162Source | 1,529,064Source | 14,535Source | 228,710Source | 1,449,265Source | 28,111Source | 1,672,155Source | — | 81,324Source | 356,165Source |
| Stockholders' Equity Attributable to Noncontrolling InterestUSD | -210,249Source | -169,800Source | -135,046Source | -203,321Source | -162,652Source | -125,948Source | -194,298Source | -155,325Source | -220,009Source | -182,312Source | -146,159Source | -111,986Source |
| Additional Financial Items | ||||||||||||
| Accrued Liabilities, CurrentUSD | — | — | — | — | — | — | — | — | — | 1,189,858Source | 607,176Source | 777,086Source |
| Deferred Tax Liabilities, NetUSD | — | — | — | — | — | — | — | — | 340,188Source | 15,216Source | — | — |
cash flow · annual statements
| Line item | Q4 2026 | Q4 2025 | Q3 2026 | Q3 2025 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | — | — | -2,869,640Source | -2,550,674Source | -2,686,613Source | -2,256,797Source | -2,994,992Source | -2,694,799Source | -12,468,672Source | -10,604,886Source | -10,190,932Source | -10,664,555Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Depreciation, Depletion and AmortizationUSD | — | — | 290,393Source | — | — | — | 257,907Source | 241,622Source | 1,163,847Source | 970,117Source | 974,355Source | 814,481Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | — | — | — | — | — | 12,000Source | 202,045Source | 195,208Source | 238,045Source | 230,496Source | 260,000Source |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in Accounts ReceivableUSD | — | — | — | — | — | — | 123,209Source | 148,874Source | 253,850Source | 164,910Source | 135,843Source | 293,861Source |
| Increase (Decrease) in InventoriesUSD | — | — | — | — | — | — | -7,038Source | -38,748Source | -216,638Source | -142,322Source | -202,370Source | 345,390Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | -2,846,825Source | -2,387,216Source | -11,927,222Source | -9,677,313Source | -9,571,569Source | -7,377,378Source |
| Cash flows from investing activities: | ||||||||||||
| Payments to Acquire Businesses, Net of Cash AcquiredUSD | — | — | — | — | — | — | — | — | — | — | — | 363,500Source |
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | — | — | — | — | -70,401Source | — | -85,573Source | -231,838Source | -221,426Source | -694,142Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | — | — | — | — | — | — | 70,401Source | — | 125,731Source | 231,838Source | 5,368Source | — |
| Cash flows from financing activities: | ||||||||||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | 3,558,165Source | 42,450Source | 14,983,706Source | 4,597,805Source | 14,560,556Source | 1,435,323Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | — | — | — | — | — | — | 640,196Source | -2,314,667Source | 2,972,403Source | -5,284,189Source | 4,766,854Source | -6,701,057Source |
| Additional Financial Items | ||||||||||||
| Share-based Payment Arrangement, ExpenseUSD | — | — | 12,204Source | 0Source | — | — | — | — | 97,633Source | — | — | — |
| Amortization of Intangible AssetsUSD | — | — | 215,644Source | 238,945Source | 212,228Source | 240,783Source | 242,369Source | 235,464Source | 1,152,537Source | 949,288Source | 947,436Source | 850,782Source |
| DepreciationUSD | — | — | — | — | — | — | — | — | 68,331Source | 14,955Source | 15,108Source | 33,769Source |
| Equity Securities, FV-NI, Gain (Loss)USD | — | — | — | — | — | — | — | — | — | — | 175,738Source | 2,154,365Source |
| Foreign Currency Transaction Gain (Loss), RealizedUSD | — | — | 32,258Source | -113Source | — | -750Source | — | -51Source | 39,820Source | -911Source | -1,178Source | -9,829Source |
| General and Administrative ExpenseUSD | — | — | — | 2,407,558Source | — | 1,809,114Source | 2,659,824Source | 1,949,016Source | 10,502,161Source | 8,883,917Source | 9,258,496Source | 8,026,703Source |
| Goodwill and Intangible Asset ImpairmentUSD | — | — | — | — | — | — | — | — | — | — | — | -4,158,670Source |
| Goodwill, Impairment LossUSD | — | — | — | — | — | — | — | — | — | — | — | 4,158,670Source |
| InterestExpenseNonoperatingUSD | — | — | 4,241Source | 7,919Source | 56,209Source | 13,502Source | 3,903Source | 22,327Source | 10,736Source | 60,890Source | — | — |
| Inventory Write-downUSD | — | — | 37,311Source | — | — | — | — | — | 62,044Source | — | 69,676Source | 189,670Source |
| Investment Income, InterestUSD | — | — | 49,444Source | 17,687Source | 5,334Source | 21,937Source | 8,504Source | 52,840Source | 110,329Source | 101,522Source | — | — |
| Net Income (Loss) Attributable to ParentUSD | — | — | -2,862,712Source | -2,543,526Source | -2,677,590Source | -2,249,470Source | -2,983,006Source | -2,685,633Source | -12,430,975Source | -10,568,733Source | -10,156,759Source | -10,631,720Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | — | — | -6,928Source | -7,148Source | -9,023Source | -7,327Source | -11,986Source | -9,166Source | -37,697Source | -36,153Source | -34,173Source | -32,835Source |
| Nonoperating Income (Expense)USD | — | — | 77,461Source | 9,655Source | -50,875Source | 7,685Source | 4,601Source | 30,462Source | 139,413Source | 39,721Source | 92,242Source | 1,930,678Source |
| Operating ExpensesUSD | — | — | 3,648,177Source | 3,074,968Source | 3,168,197Source | 2,621,235Source | 3,711,151Source | 3,198,190Source | 15,335,855Source | 12,708,367Source | 12,133,576Source | 13,659,529Source |
| Operating Lease, ExpenseUSD | — | — | — | — | — | — | — | — | 435,921Source | — | — | — |
| Other Nonoperating Income (Expense)USD | — | — | 77,461Source | 9,655Source | -50,876Source | 7,685Source | — | — | 139,413Source | — | — | — |
| Impairment of Intangible Assets, Finite-lived | — | — | — | — | — | — | — | —Source | — | — | — | — |
| Proceeds from Issuance of Common Stock | — | — | — | —Source | — | —Source | — | —Source | — | — | — | — |
income statement · annual statements
| Line item | Q4 2026 | Q4 2025 | Q3 2026 | Q3 2025 | Q2 2026 | Q2 2025 | Q1 2026 | Q1 2025 | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total RevenueUSD | — | — | 1,060,802Source | 728,867Source | 896,774Source | 607,494Source | 1,111,797Source | 872,287Source | 4,215,175Source | 3,052,532Source | 3,111,781Source | 1,256,872Source |
| Cost of Goods and Services Sold | — | — | —Source | —Source | —Source | —Source | —Source | —Source | —Source | —Source | —Source | —Source |
| Selling, General and Administrative ExpenseUSD | — | — | 2,458,605Source | 2,414,639Source | 2,337,041Source | 1,809,114Source | — | — | 10,502,161Source | — | — | — |
| Operating Income (Loss)USD | — | — | -2,947,101Source | -2,560,329Source | -2,635,738Source | -2,264,482Source | -2,999,593Source | -2,725,261Source | -12,608,085Source | -10,644,607Source | -10,283,174Source | -12,595,233Source |
| Other Nonoperating Income (Expense)USD | — | — | 77,461Source | 9,655Source | -50,876Source | 7,685Source | — | — | 139,413Source | — | — | — |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | — | — | -6,928Source | -7,148Source | -9,023Source | -7,327Source | -11,986Source | -9,166Source | -37,697Source | -36,153Source | -34,173Source | -32,835Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -2,862,712Source | -2,543,526Source | -2,677,590Source | -2,249,470Source | -2,983,006Source | -2,685,633Source | -12,430,975Source | -10,568,733Source | -10,156,759Source | -10,631,720Source |
| Earnings Per Share, BasicUSD per share | — | — | -1.8Source | -4.41Source | -2.82Source | -4.96Source | -0.35Source | -0.7Source | -8.44Source | -2Source | -6.38Source | -10.58Source |
| Earnings Per Share, DilutedUSD per share | — | — | -1.8Source | -4.41Source | -2.82Source | -4.96Source | -0.35Source | -0.7Source | -8.44Source | -2Source | -6.38Source | -10.58Source |
| Weighted Average Number of Shares Outstanding, Basicshares | — | — | 1,594,496Source | 577,191Source | 950,829Source | 453,582Source | 8,546,934Source | 3,811,090Source | 1,472,744Source | 5,273,643Source | 1,592,746Source | 1,004,593Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | — | — | 1,594,496Source | 577,191Source | 950,829Source | 453,582Source | 8,546,934Source | 3,811,090Source | 1,472,744Source | 5,273,643Source | 1,592,746Source | 1,004,593Source |
| Interest Expense (non-operating)USD | — | — | 4,241Source | 7,919Source | 56,209Source | 13,502Source | 3,903Source | 22,327Source | 10,736Source | 60,890Source | — | — |
| Additional Financial Items | ||||||||||||
| Amortization of Intangible AssetsUSD | — | — | 215,644Source | 238,945Source | 212,228Source | 240,783Source | 242,369Source | 235,464Source | 1,152,537Source | 949,288Source | 947,436Source | 850,782Source |
| Depreciation, Depletion and Amortization, NonproductionUSD | — | — | 290,393Source | 301,978Source | 281,896Source | 305,177Source | 303,378Source | 300,422Source | 1,163,847Source | 1,207,875Source | 1,201,274Source | 966,732Source |
| Foreign Currency Transaction Gain (Loss), RealizedUSD | — | — | 32,258Source | -113Source | — | -750Source | — | -51Source | 39,820Source | -911Source | -1,178Source | -9,829Source |
| General and Administrative ExpenseUSD | — | — | — | 2,407,558Source | — | 1,809,114Source | 2,659,824Source | 1,949,016Source | 10,502,161Source | 8,883,917Source | 9,258,496Source | 8,026,703Source |
| Goodwill, Impairment LossUSD | — | — | — | — | — | — | — | — | — | — | — | 4,158,670Source |
| Gross ProfitUSD | — | — | 535,381Source | 341,368Source | 459,739Source | 223,113Source | 518,291Source | 346,801Source | 2,049,994Source | 1,246,859Source | 1,425,626Source | 326,668Source |
| Interest and Other IncomeUSD | — | — | — | — | — | — | — | — | — | — | 84,822Source | 9,676Source |
| Investment Income, InterestUSD | — | — | 49,444Source | 17,687Source | 5,334Source | 21,937Source | 8,504Source | 52,840Source | 110,329Source | 101,522Source | — | — |
| Nonoperating Income (Expense)USD | — | — | 77,461Source | 9,655Source | -50,875Source | 7,685Source | 4,601Source | 30,462Source | 139,413Source | 39,721Source | 92,242Source | 1,930,678Source |
| Operating ExpensesUSD | — | — | 3,648,177Source | 3,074,968Source | 3,168,197Source | 2,621,235Source | 3,711,151Source | 3,198,190Source | 15,335,855Source | 12,708,367Source | 12,133,576Source | 13,659,529Source |
| Operating Lease, ExpenseUSD | — | — | — | — | — | — | — | — | 435,921Source | — | — | — |
| Other IncomeUSD | — | — | — | 37,915Source | — | 56,078Source | — | 16,041Source | — | 271,780Source | — | — |
Offerings
Registration 333-298951
Registration 333-292656
Filing attachments
ex107.htm · S-3 · 2026-09-15
Calculation of Filing Fee Tables S-3 INTELLIGENT BIO SOLUTIONS INC. ──────────────────────────────────── Table 1: Newly Registered and Carry Forward Securities ☐Not Applicable ─────────────────────────────────────────────────────────────────────────────── Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate …
Read attachment ↗ex99-1.htm · 8-K · 2026-09-09
EX-99.1 2 ex99-1.htm EX-99.1 Exhibit 99.1 Intelligent Bio Solutions Submits FDA 510(k) Package for Intelligent Fingerprinting Drug Screening System, Seeking U.S. Market Clearance Submission package includes Method Comparison Study, which delivered accuracy above 98%, sensitivity above 94%, and 100% specificity across three independent U.S. clinical sites. NEW YORK, September 09, 2026 - Intelligent Bio Solutions Inc. (Nasdaq: INBS) (“INBS” or the “Company”), a medical technology company de…
Read attachment ↗ex4-1.htm · 8-K · 2026-09-02
EX-4.1 2 ex4-1.htm EX-4.1 Exhibit 4.1 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE …
Read attachment ↗ex4-2.htm · 8-K · 2026-09-02
EX-4.2 3 ex4-2.htm EX-4.2 Exhibit 4.2 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE …
Read attachment ↗ex4-3.htm · 8-K · 2026-09-02
EX-4.3 4 ex4-3.htm EX-4.3 Exhibit 4.3 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE …
Read attachment ↗